Takayuki Abe

6PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCondensed matter imagingCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

|May 14, 2026
Estimation of Lung Volume Superimposed on the Mediastinum and Diaphragm on Chest Radiographs Using Upright Multidetector Row CT.

|Jan 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trial.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|Oct 25, 2025
Strong inhibition of IL-6 signal is clinically and serologically effective in refractory adult-onset Still's disease.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|Jun 14, 2025
Serum cytokine levels towards precision medicine in Still's disease: a subanalysis of a randomized controlled trial of tocilizumab.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|May 14, 2025
Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter-Related Venous Phlebitis in Critically Ill Patients Using a Time-Dependent Multilevel Cox Regression Model.

Hideto Yasuda, Claire M Rickard, Jessica A Schults

Pageof 1

Frequent Collaborators

4 joint publications

Tomonori Ishii

4 joint publications

Yoshiya Tanaka

4 joint publications

Kosaku Murakami

4 joint publications

Yuko Kaneko